25 studies found for:
"Li Fraumeni syndrome"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
|
||||
| 2 | Recruiting |
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
|
||||
| 3 | Recruiting |
Clinical and Genetic Studies of Li-Fraumeni Syndrome
|
||||
| 4 | Recruiting |
LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
|
||||
| 5 | Recruiting |
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
|
||||
| 6 | Unknown † |
rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
|
||||
| 7 | Unknown † |
rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors
|
||||
| 8 | Not yet recruiting |
Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma
|
||||
| 9 | Terminated |
Wild Type p53 Adenovirus for Oral Premalignancies
|
||||
| 10 | Active, not recruiting |
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
|
||||
| 11 | Recruiting |
A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004 AM5)
|
||||
| 12 | Completed |
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
|
||||
| 13 | Unknown † |
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
|
||||
| 14 | Completed |
Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
|
||||
| 15 | Active, not recruiting |
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
|
||||
| 16 | Unknown † |
Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
|
||||
| 17 | Recruiting |
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
|
||||
| 18 | Completed |
Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
|
||||
| 19 | Completed |
Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies
|
||||
| 20 | Active, not recruiting |
Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
|
† Indicates status has not been verified in more than two years
